联合微创开颅、术中磁共振成像与清醒功能定位切除胶质瘤61例
该研究回顾性分析了2010至2017年间在iMRI手术室接受微创开颅联合清醒功能定位的61例胶质瘤患者(共62次肿瘤切除)。iMRI显示48例(77.4%)有残留肿瘤,其中41例(85.4%)进一步切除;iMRI与术后MRI的中位切除程度分别为86.0%和98.5%(P<0.001)。作者认为该联合方法安全可行。
要点
- iMRI显示48例(77.4%)有残留肿瘤,其中41例(85.4%)接受了进一步切除。
- iMRI与术后MRI的中位切除程度分别为86.0%与98.5%(P<0.001)。
- 作者认为iMRI联合清醒功能定位安全可行,可兼顾最大切除与最小功能损害。
核心结论
- 在这项回顾性病例系列中,iMRI联合清醒功能定位被证明安全可行,可使胶质瘤切除患者兼顾最大肿瘤切除与最小功能后果的双重目标。
研究设计与样本
- 回顾性病例系列,纳入2010至2017年间在iMRI手术室(IMRIS)接受微创开颅联合清醒功能定位的胶质瘤患者,共61例、62次肿瘤切除符合纳入标准。
主要发现
- 45.9%的肿瘤为WHO I或II级,54.1%为WHO III或IV级。
- 术中神经电生理监测方式为仅语言23例(37.1%)、仅运动24例(38.7%)、语言与运动均做15例(24.2%)。
- iMRI与术后MRI的中位切除程度分别为86.0%和98.5%,平均差10%、中位差10.5%(P<0.001)。
- 62例次中17例次因使用iMRI使切除程度增加超过15%;低级别胶质瘤28例中17例(60.7%)和高级别胶质瘤33例中10例(30.3%)实现完全切除。
- 语言定位38例中7例(18.4%)出现至少暂时性新发或加重的语言改变;运动定位39例中7例(18.0%)出现新发或加重的无力;麻木2例(3.2%)、躁动2例(3.2%)、癫痫发作2例(3.2%)。
临床怎么用
- 作者认为,iMRI联合清醒功能定位安全可行,可在胶质瘤切除中兼顾最大肿瘤切除与最小功能后果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Current management of gliomas involves a multidisciplinary approach, including a combination of maximal safe resection, radiotherapy, and chemotherapy. The use of intraoperative MRI (iMRI) helps to maximize extent of resection (EOR), and use of awake functional mapping supports preservation of eloquent areas of the brain. This study reports on the combined use of these surgical adjuncts. METHODS: The authors performed a retrospective review of patients with gliomas who underwent minimal access craniotomy in their iMRI suite (IMRIS) with awake functional mapping between 2010 and 2017. Patient demographics, tumor characteristics, intraoperative and postoperative adverse events, and treatment details were obtained. Volumetric analysis of preoperative tumor volume as well as intraoperative and postoperative residual volumes was performed. RESULTS: A total of 61 patients requiring 62 tumor resections met the inclusion criteria. Of the tumors resected, 45.9% were WHO grade I or II and 54.1% were WHO grade III or IV. Intraoperative neurophysiological monitoring modalities included speech alone in 23 cases (37.1%), motor alone in 24 (38.7%), and both speech and motor in 15 (24.2%). Intraoperative MRI demonstrated residual tumor in 48 cases (77.4%), 41 (85.4%) of whom underwent further resection. Median EOR on iMRI and postoperative MRI was 86.0% and 98.5%, respectively, with a mean difference of 10% and a median difference of 10.5% (p < 0.001). Seventeen of 62 cases achieved an increased EOR > 15% related to use of iMRI. Seventeen (60.7%) of 28 low-grade gliomas and 10 (30.3%) of 33 high-grade gliomas achieved complete resection. Significant intraoperative events included at least temporary new or worsened speech alteration in 7 of 38 cases who underwent speech mapping (18.4%), new or worsened weakness in 7 of 39 cases who underwent motor mapping (18.0%), numbness in 2 cases (3.2%), agitation in 2 (3.2%), and seizures in 2 (3.2%). Among the patients with new intraoperative deficits, 2 had residual speech difficulty, and 2 had weakness postoperatively, which improved to baseline strength by 6 months. CONCLUSIONS: In this retrospective case series, the combined use of iMRI and awake functional mapping was demonstrated to be safe and feasible. This combined approach allows one to achieve the dual goals of maximal tumor removal and minimal functional consequences in patients undergoing glioma resection.
引用
- Whiting BB, Lee BS, Mahadev V, et al. Combined use of minimal access craniotomy, intraoperative magnetic resonance imaging, and awake functional mapping for the resection of gliomas in 61 patients. J Neurosurg. 2019. PMID: 30684941. doi:10.3171/2018.9.JNS181802
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。